NDLI: IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate

Content Provider	PubMed Central
Author	Le, Thuy T. Skak, Kresten Schroder, Kate Schroder, Wayne A. Boyle, Glen M. Pierce, Carly J. Suhrbier, Andreas
Editor	Lebedeva, Irina V.
Copyright Year	2016
Abstract	Ingenol mebutate is approved for the topical treatment of actinic keratoses and may ultimately also find utility in treating skin cancers. Here we show that relapse rates of subcutaneous B16 melanoma tumours treated topically with ingenol mebutate were not significantly different in C57BL/6 and Rag1-/- mice, suggesting B and T cells do not play a major role in the anti-cancer efficacy of ingenol mebutate. Relapse rates were, however, significantly increased in MyD88-/- mice and in C57BL/6 mice treated with the anti-IL-1 agent, anakinra. Ingenol mebutate treatment induces a pronounced infiltration of neutrophils, which have been shown to have anti-cancer activity in mice. Herein we provide evidence that IL-1 promotes neutrophil recruitment to the tumour, decreases apoptosis of infiltrating neutrophils and increases neutrophil tumour killing activity. These studies suggest IL-1, via its action on neutrophils, promotes the anti-cancer efficacy of ingenol mebutate, with ingenol mebutate treatment causing both IL-1β induction and IL-1α released from keratinocytes.
Related Links	http://dx.doi.org/10.1371/journal.pone.0153975
Starting Page	153975
File Format	PDF
ISSN	19326203
e-ISSN	19326203
Journal	PLoS ONE
Issue Number	4
Volume Number	11
Language	English
Publisher	Public Library of Science
Publisher Date	2016-04-21
Access Restriction	Open
Rights Holder	Public Library of Science
Subject Keyword	Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Multidisciplinary

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Efficacy, safety and tolerability of field treatment of actinic keratosis with ingenol mebutate 0.015 % gel: a single center case series

Ingenol Mebutate: Potential for Further Development of Cancer Immunotherapy

Efficacy, safety and tolerability of field treatment of actinic keratosis with ingenol mebutate 0.015 % gel: a single center case series

Ingenol Mebutate: An Emerging Therapy in the Treatment of Actinic Keratoses

Ingenol Mebutate Gel (Picato)

Efficacy of ingenol mebutate gel for actinic keratosis in patients treated by thiazide diuretics

The Role of Ingenol Mebutate in the Treatment of Actinic Keratoses

Ingenol Mebutate for the Treatment of Actinic Keratosis

Ingenol Mebutate: A Succinct Review of a Succinct Therapy

IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate

Similar Documents

Efficacy, safety and tolerability of field treatment of actinic keratosis with ingenol mebutate 0.015 % gel: a single center case series

Ingenol Mebutate: Potential for Further Development of Cancer Immunotherapy

Efficacy, safety and tolerability of field treatment of actinic keratosis with ingenol mebutate 0.015 % gel: a single center case series

Ingenol Mebutate: An Emerging Therapy in the Treatment of Actinic Keratoses

Ingenol Mebutate Gel (Picato)

Efficacy of ingenol mebutate gel for actinic keratosis in patients treated by thiazide diuretics

The Role of Ingenol Mebutate in the Treatment of Actinic Keratoses

Ingenol Mebutate for the Treatment of Actinic Keratosis

Ingenol Mebutate: A Succinct Review of a Succinct Therapy

IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate